Cancer Research Technology
Log in Register
Menu

Anti-Leu1 [Y2/178]

Invented by Dr Jacqueline Cordell from University of Oxford
Invented at University of Oxford

Info

Catalogue Number 151344
Applications FACS IHC IF IP WB
Antigen/Gene or Protein Targets Leu1 (CD5)
Synonyms CD5 Molecule 2; Lymphocyte Antigen T1/Leu-1; LEU1; CD5 Antigen; T1
Reactivity Human
Relevance CD5 is a surface glycoprotein present on peripheral T cells (>95%) and B-cell chronic lymphocytic leukaemia cells that binds CD72. CD5 has utility for the monitoring of T-cell numbers in peripheral blood and the identification of leukaemias of T cell origin. Absence of the CD5 marker on childhood ALL cells is associated with a more favourable prognosis.
Host Mouse
Immunogen Normal lymphocytes treated with PHA (phytohaemagglutinin)
Subclass IgG1
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions RPMI 1640 + 10% FCS + penicillin (100U/ml) + streptomycin (100mg/l) + glutamine (2mM) + HAT
Notes Ultroser G can be used at 1% if the cells are not growing well.
Research Area Immunology, Stem Cell Biology

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Hassan et al. 2006. Mol Cell Biol. 26(17):6727-38. PMID: 16914752.

CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.

Europe PMC ID: 16914752


Add a reference

References: 2 entries

Hassan et al. 2006. Mol Cell Biol. 26(17):6727-38. PMID: 16914752.

CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.


Add a reference